Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PeriphaGen
AddedFeb 15, 2024
UpdatedJun 18, 2026
PeriphaGen

PeriphaGen

Series A

PeriphaGen: A biopharmaceutical firm innovating neuronal gene therapies for neurologic disorders.

HQ
Pittsburgh, PA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

PeriphaGen, founded with a mission to revolutionize the treatment of neurologic disorders, is a biopharmaceutical company specializing in neuronal gene therapies. The company focuses on developing first-in-class gene delivery products using herpes simplex virus type I (HSV-1) vectors to target neurons directly. Their primary areas of interest include neuropathic pain, neuropathy, and neuronal regeneration, addressing significant unmet medical needs in these domains.

Notable figures associated with PeriphaGen include experts in virology and gene therapy, contributing to their innovative approach. The company has achieved significant milestones in developing HSV-1 vectors, showcasing their potential in treating nervous system diseases. PeriphaGen's impact lies in its pioneering methods and commitment to advancing therapeutic options for neurologic conditions, positioning it as a leader in the biopharmaceutical industry.

PeriphaGen - Similar Companies

Neurogene logo

Neurogene

neurogene.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Empyrean Neuroscience logo

Empyrean Neuroscience

empyrean.bio

Neurovia logo

Neurovia

Spinogenix logo

Spinogenix

spinogenix.com

Orphion Therapeutics logo

Orphion Therapeutics

Apertura Gene Therapy logo

Apertura Gene Therapy

aperturagtx.com

Neuright logo

Neuright

neurightlabs.com

Intergalactic Therapeutics logo

Intergalactic Therapeutics

Pagari Life Science logo

Pagari Life Science

Coda Biotherapeutics logo

Coda Biotherapeutics

Oculogenex logo

Oculogenex

oculogenex.com

ReNeuroGen logo

ReNeuroGen

rngen.com

Neuropathix logo

Neuropathix

neuropathix.com

Permeon Biologics logo

Permeon Biologics

permeonbio.com

PeriphaGen - Quick Facts

Who are PeriphaGen's competitors?

Companies similar to PeriphaGen include Neurogene, NeuroTherapeutics Pharma, Empyrean Neuroscience and Neurovia.

When was PeriphaGen founded?

PeriphaGen was founded in 2012.

Where is PeriphaGen's headquarters located?

PeriphaGen's headquarters is located in Pittsburgh, PA, US.

When was PeriphaGen's last funding round?

PeriphaGen's most recent funding round was for $6.5M (USD) in April 2014.

How much has PeriphaGen raised to-date?

As of Apr 1, 2014, PeriphaGen has raised a total of $6.5M (USD).

How many employees does PeriphaGen have?

PeriphaGen has 8 employees as of Feb 5, 2024.

PeriphaGen - Classification

Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Gene Therapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified